Skip to main content

Featured

Patrick Nip visits AXA

Secretary for the Civil Service Patrick Nip today visited AXA Hong Kong & Macau to view the administering of COVID-19 vaccines.   About 360 staff and agents of the enterprise will receive either a Sinovac or BioNTech vaccine during a two-day outreach vaccination service by the Government.   Mr Nip said the Government welcomes enterprises to join hands with it in promoting the Early Vaccination for All campaign and encourages their employees to support the vaccination programme to protect the health of themselves, colleagues and clients.   He also hoped that people who get vaccinated will encourage their families and friends to do the same as a way to help build an immune barrier in Hong Kong.   He called on the public to get vaccinated as early as possible, noting that the vaccination programme is already offering more quotas for people to make bookings, and same-day tickets for vaccinations will be distributed to seniors aged 70 or above starting tomorrow.   Elderly peop

Myocarditis after jab reported

The Department of Health today said it received from the Hospital Authority a total of three reports of suspected myocarditis for adolescents who have received BioNTech vaccines up to July 19 and their conditions were stable.   In response to media enquiries, the department noted around 63,000 doses of BioNTech vaccines have been administered to adolescents aged 12 to 15 in the same period.   The three cases involved one 12-year-old and two 15-year-old boys. They complained of chest pain about two days after receiving the second dose of BioNTech vaccine.   They were all admitted to the authority's hospitals for monitoring and treatment, and their conditions were stable.   These cases will be passed to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization for causality assessment.   The expert committee noted that there were reports from overseas drug regulatory authorities about cases of myocarditis and pericarditis following vaccination, especially among younger vaccine recipients.   The committee has endorsed the inclusion of myocarditis and pericarditis in the list of serious or unexpected adverse events following immunisation to enhance monitoring.   The department has also been closely monitoring adverse events of myocarditis or pericarditis among adolescents of 12 to 15 years old.   According to the BioNTech vaccine manufacturer, cases of myocarditis and pericarditis have primarily occurred within 14 days following vaccination, more often after the second vaccination and in younger men.   The supplier has also updated the product's package insert to include myocarditis and pericarditis as its adverse reactions.   The department reminded adolescents and young adults to avoid strenuous exercise for one week after vaccination.   They should seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis such as acute and persisting chest pain, shortness of breath or palpitations following vaccination.
http://dlvr.it/S45Jm5

Popular Posts